Evidence map›Paper›PMID 34855852›Full record

ArticlePloS one2021

A specific structure and high richness characterize intestinal microbiota of HIV-exposed seronegative individuals.

Tulio J Lopera, Jorge A Lujan, Eduardo Zurek, Wildeman Zapata, Juan C Hernandez, Miguel A Toro, Juan F Alzate, Natalia A Taborda, Maria T Rugeles, Wbeimar Aguilar-Jimenez

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tulio J LoperaFacultad de Medicina, Grupo Inmunovirología, Universidad de Antioquia UdeA, Medellín, Colombia.
Jorge A LujanFacultad de Medicina, Grupo Inmunovirología, Universidad de Antioquia UdeA, Medellín, Colombia.
Eduardo ZurekDepartment of System Engineering, Universidad del Norte, Barranquilla, Colombia.
Wildeman ZapataFacultad de Medicina, Grupo Inmunovirología, Universidad de Antioquia UdeA, Medellín, Colombia.
Juan C HernandezFacultad de Medicina, Grupo Infettare, Universidad Cooperativa de Colombia, Medellín, Colombia.ORCID 0000-0002-9200-5698
Miguel A ToroFacultad de Medicina, Centro Nacional de Secuenciación Genómica -CNSG, Sede de Investigación Universitaria -SIU, Universidad de Antioquia UdeA, Medellin, Colombia.
Juan F AlzateFacultad de Medicina, Centro Nacional de Secuenciación Genómica -CNSG, Sede de Investigación Universitaria -SIU, Universidad de Antioquia UdeA, Medellin, Colombia.
Natalia A TabordaFacultad de Medicina, Grupo Inmunovirología, Universidad de Antioquia UdeA, Medellín, Colombia.
Maria T RugelesFacultad de Medicina, Grupo Inmunovirología, Universidad de Antioquia UdeA, Medellín, Colombia.
Wbeimar Aguilar-JimenezFacultad de Medicina, Grupo Inmunovirología, Universidad de Antioquia UdeA, Medellín, Colombia.ORCID 0000-0002-0790-055X
Universidad de Antioquia · COUniversidad Cooperativa de Colombia · COUniversidad del Norte · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal microbiota facilitates food breakdown for energy metabolism and influences the immune response, maintaining mucosal homeostasis. Overall, HIV infection is associated with intestinal dysbiosis and immune activation, which has been related to seroconversion in HIV-exposed individuals. However, it is unclear whether microbiota dysbiosis is the cause or the effect of immune alterations and disease progression or if it could modulate the risk of acquiring the HIV infection. We characterize the intestinal microbiota and determine its association with immune regulation in HIV-exposed seronegative individuals (HESN), HIV-infected progressors (HIV+), and healthy control (HC) subjects. For this, feces and blood were collected. The microbiota composition of HESN showed a significantly higher alpha (p = 0.040) and beta diversity (p = 0.006) compared to HC, but no differences were found compared to HIV+. A lower Treg percentage was observed in HESN (1.77%) than HC (2.98%) and HIV+ (4.02%), with enrichment of the genus Butyrivibrio (p = 0.029) being characteristic of this profile. Moreover, we found that Megasphaera (p = 0.017) and Victivallis (p = 0.0029) also are enriched in the microbiota composition in HESN compared to HC and HIV+ subjects. Interestingly, an increase in Succinivibrio and Prevotella, and a reduction in Bacteroides genus, which is typical of HIV-infected individuals, were observed in both HESN and HIV+, compared to HC. Thus, HESNs have a microbiota profile, similar to that observed in HIV+, most likely because HESN are cohabiting with their HIV+ partners.

Indexed as

Gastrointestinal MicrobiomeAdolescentAdultButyrivibrioCase-Control StudiesFecesFemaleHIV InfectionsHIV SeronegativityHumansMaleMegasphaeraMiddle AgedPrevotellaTh17 CellsT-Lymphocytes, Regulatory

Identifiers

PMID34855852
PMCPMC8638974
OpenAlexW3216816024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.